Amid the growing demand for GLP-1 medications for weight loss, a new experimental drug, retatrutide, stands out, according to new clinical trial results released on Thursday
Stacking appetite suppressants or stimulant products on top of a GLP1 is generally not recommended unless your clinician specifically advises it
However, because Gallups method of collecting self-reported weight and height has been consistent, the trend still provides valuable information about change over time
Skin rejuvenation: The process of improving the appearance and health of the skin through various treatments or procedures, often involving collagen stimulation, skin tightening, and texture improvement
Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, whereas semaglutide activates only the GLP-1 receptor and tirzepatide activates both GLP-1 and GIP receptors
More trips to the loo, and dehydration creeps closer
